Unbiased AI-powered news
2 stories related to this topic, newest first.
StatBeOne Medicines received FDA approval for its BCL-2 inhibitor Beqalzi to treat relapsed or refractory mantle cell lymphoma. The drug is the first BCL-2 inhibitor specifically cleared for this indication in the U.S. Separately, CREATE Medicines raised $122 million to advance its i…
hitconsultant.netBioticsAI, an AI startup focused on detecting fetal abnormalities via ultrasound, secured FDA approval in January 2026. The company is now rolling out its technology in hospitals and plans expansion into broader reproductive health areas. Co-founder Robhy Bustami discussed the fi…